Ergoteles’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Ergoteles’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-443,928	Closed	-$7.49M	–	995
2023 Q2	$7.49M	Buy	+443,928	New	+$5.84M	0.36%	60

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return

Ergoteles's VECT Position: Q3 2023 in Review

Ergoteles sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 443,928 shares — an estimated $7.49M sold.

Ergoteles first reported a position in VECT in Q2 2023 and held it in 1 quarter. The position peaked at $7.49M in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

Ergoteles reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 443,928 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $7.49M.
Ergoteles first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2023 and held it in 1 quarter.
Ergoteles's VectivBio Holding AG Ordinary Shares position peaked at $7.49M in Q2 2023.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.